期刊文献+

CpG ODN增强乙肝疫苗免疫反应的研究

Study of the immunological enhancement of HBV vaccine with CpG ODN
下载PDF
导出
摘要 目的研究人工合成的CpG ODN对乙肝表面抗原的免疫增强效应,评价CpG ODN的佐剂效应。方法将不同剂量特定的CpG ODN与乙肝表面抗原联合免疫小鼠,用ELISA检测小鼠乙肝表面抗体的滴度。结果CpG ODN联合乙肝表面抗原免疫小鼠,在短期检测中,高剂量组能较快的达到检测阈,各剂量组间抗体滴度检测值差异有显著性(P<0.05),在长期检测中,各剂量组间抗体滴度检测值差异有显著性(P<0.05),检测值随CpG剂量的增高而增大。结论CpG ODN增强乙肝表面抗原的免疫反应短期和长期都具有剂量效应。 Objective To investigate the effects of immunological enhancement of HBsAg with synthetic CpG oligodeoxynucleotides, evaluate the adjuvant effect of CpG ODN. Methods Mice were vaccinated with CpG oligodeoxynucledtides and HBsAg at different doses, and then titers of HBsAb in the blood serums of mice were detected with ELISA. Results CpG ODN and HBsAg immunize the BALb/c mice, the high-dose group could be detected quickly in shot term, the levels of antibodies in groups which use different doses of CpG ODN and HBsAg were different in statics(P 〈0.05) ,in long term the levels of antibodies in groups which use different doses of CpG ODN and HBsAg were different in statics ( P 〈 0.05 ), the levels of antibodies were corresponded with the levels of CpG ODN ( P 〈 0. 05 ). Conclusion The immunological effect of HBsAg was enhanced with CpG ODN as adjuvant in short and long terms.
出处 《广东药学院学报》 CAS 2009年第3期314-317,共4页 Academic Journal of Guangdong College of Pharmacy
基金 广东省科技计划项目(2007B03072008)
关键词 CPG ODN 乙肝表面抗原 免疫佐剂 体液免疫 CpG ODN HBsAg immunoadjuvant humoral immunity
  • 相关文献

参考文献10

  • 1YAMAMOTO M,SATO S,MORI K,et al.Cutting edge:a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling[J].J Immunol,2002,169:6668-6672.
  • 2罗耀星,李建基,张吉凯,蔡汉港,阳文胜.广东省1997~2002年新生儿乙型肝炎疫苗接种率及其影响因素分析[J].中国计划免疫,2006,12(2):100-102. 被引量:14
  • 3冯春颜,汪宇婴,赵祥胜.乙肝疫苗接种后无弱应答分析[J].热带医学杂志,2005,5(3):405-406. 被引量:12
  • 4DAVIS H L.Use of CpG DNA for enhancing specific immune responses[J].Curr Top Microbiol Immunol,2000,247:171-183.
  • 5MOLDOVEANU Z,LOVE-HOMAN L,HUANG W Q,et al.CpG DNA,a novel immune enhancer for systemic and mucosal immunization with influenza virus[J].Vaccine,1998,16(11/12):1216-1224.
  • 6KRIEG A M.The role of CpG motifs in innate immunity[J].Curr Opin Immunol,2000,12:35-45.
  • 7KLINMAN D M,CURRIE D,GURSEL I,et al.Use of CpG oligodeoxynucleotides as immune adjuvants[J].Immunol Rev,2004,199,201-216.
  • 8KLINMAN D M.CpG DNA as a vaccine adjuant[J].Expert Rev Vaccine,2003,2:305-315.
  • 9HALPERIN S A,VAN N G,SMITH B,et al.A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant[J].Vaccine,2003,21:2461-2467.
  • 10VANOSTEN R L,GRIFFITH T S.Activation of tumor-specific CD8+T cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy[J].Cancer Res,2007,67:(24):11980-11990.

二级参考文献19

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部